CCL20 is an inflammatory chemokine, which is upregulated during inflammation to recruit primarily CCR6-expressing leukocytes (70), with a well-established role in diseases such as multiple sclerosis or its animal model experimental autoimmune encephalomyelitis (71). Here, CCL20 is linked to experimental autoimmune encephalomyelitis.